Cross-linked PVA Scaffolds for 3D Printed Tissue Replacements
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tissue replacements face challenges due to a lack of appropriate donors, tissue typing, availability, homogeneity, and variety, leading to transplant failures, and existing 3D printing techniques are complex and expensive, requiring specialized facilities and materials, particularly with polyvinyl alcohol (PVA) being difficult to use in its unmodified state for biological devices.
Innovation Solution
The development of cross-linked polyvinyl alcohol scaffolds using aldehyde cross-linking, such as with glutaraldehyde, and the incorporation of medically functional chemicals like iodine, which can be loaded via gas sublimation, to create biologically compatible, flexible, and stable matrices suitable for 3D printing of tissue replacements, including vascular stents and wound care products.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If polyvinyl alcohol is used as a water soluble support matrix for 3D printing, then complex structures can be printed rapidly, but the material is challenging to use for biological devices in its unmodified state
Solution Approach 1:
The patent applies chemical cross-linking transformation to convert PVA from water-soluble to water-insoluble state, changing its physical and chemical parameters to achieve both rapid dissolution capability for printing and biological stability for medical applications. The cross-linking degree and network density are controlled to balance solubility and stability.
Solution Approach 2:
The patent creates composite material systems by combining cross-linked PVA with various bioactive molecules, growth factors, and cellular components. This composite approach maintains the rapid dissolution特性 of PVA while adding biological functionality and stability required for medical devices.
2Adaptability or versatility
If current 3D printing techniques are used for tissue replacements, then tissue structures can be created, but the process is highly complex and requires specialized laboratory and printing facility with expensive materials
Solution Approach 1:
The patent employs disposable, commercially available PVA filaments that can be used with standard 3D printers, eliminating the need for expensive specialized equipment. The material is designed to be used once and then dissolved, reducing the need for complex sterilization and processing facilities.
Solution Approach 2:
The patent extracts the essential printing function from complex specialized facilities and transfers it to standard 3D printers by using PVA's unique rapid dissolution property. This allows the support structure to be printed and then automatically removed through dissolution, eliminating the need for complex support removal mechanisms.
3Ease of manufacture
If PVA is used as a support matrix, then rapid dissolution permits complex structure printing, but it cannot covalently bind growth factors or integrate living cells in its unmodified state
Solution Approach 1:
The patent performs preliminary cross-linking of PVA before 3D printing to create a stable network that can subsequently bind growth factors and cells. This pre-treatment ensures that the support matrix maintains structural integrity during printing while acquiring the biological functionality needed for tissue regeneration.
Solution Approach 2:
The patent uses cross-linking agents and bioactive molecules as intermediaries to bridge the gap between PVA's rapid dissolution property and its biological functionality. These intermediaries enable covalent binding of growth factors and cellular integration while maintaining the rapid dissolution characteristic for support removal.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the creation of biologically compatible, stable, and versatile 3D printing scaffolds that can covalently bind growth factors and integrate living cells, addressing the limitations of current technologies by providing a simple, accessible, and cost-effective method for generating a wide variety of tissue types and grafts.
Implementation Method 1
the polyvinyl alcohol is cross-linked by a reaction including an aldehyde
Implementation Method 2
the medically functional chemical is iodine and further comprising a step of loading the iodine on the polyvinyl alcohol via gas sublimation
Data Source
AI summary
A medical device comprising a structure formed of polyvinyl alcohol.